Ftse Mib
38.655,30
1,73%
DAX
22.986,82
2,01%
S&P 500
5.638,94
2,13%
NASDAQ
17.754,09
2,61%
Bitcoin
84.214,79
-0,16%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Rani Therapeutics Holdings Inc (RANI) Rani Therapeutics Holdings Inc (RANI) Notizie

RANI

Rani Therapeutics (RANI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RANI
DataOraFonteTitoloSimboloCompagnia
05/02/202522:05GlobeNewswire Inc.Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HCNASDAQ:RANIRani Therapeutics Holdings Inc
17/12/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
14/11/202414:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RANIRani Therapeutics Holdings Inc
14/11/202414:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
14/11/202414:00GlobeNewswire Inc.Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
07/11/202422:05GlobeNewswire Inc.Rani Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
17/10/202414:00GlobeNewswire Inc.Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin TriagonistNASDAQ:RANIRani Therapeutics Holdings Inc
16/10/202412:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RANIRani Therapeutics Holdings Inc
15/10/202414:30GlobeNewswire Inc.Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing WarrantsNASDAQ:RANIRani Therapeutics Holdings Inc
08/10/202422:05GlobeNewswire Inc.Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:RANIRani Therapeutics Holdings Inc
03/09/202422:05GlobeNewswire Inc.Rani Therapeutics to Participate in September Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
06/08/202422:05GlobeNewswire Inc.Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
29/07/202422:05GlobeNewswire Inc.Rani Therapeutics to Participate in August Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
22/07/202414:30GlobeNewswire Inc.Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct OfferingNASDAQ:RANIRani Therapeutics Holdings Inc
24/06/202413:00GlobeNewswire Inc.Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity TreatmentNASDAQ:RANIRani Therapeutics Holdings Inc
14/05/202414:00GlobeNewswire Inc.Rani Therapeutics to Participate in May Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
09/05/202414:00GlobeNewswire Inc.Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024NASDAQ:RANIRani Therapeutics Holdings Inc
06/05/202422:05GlobeNewswire Inc.Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
20/03/202421:05GlobeNewswire Inc.Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
15/03/202421:05GlobeNewswire Inc.Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:RANIRani Therapeutics Holdings Inc
05/02/202414:00GlobeNewswire Inc.Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)NASDAQ:RANIRani Therapeutics Holdings Inc
14/12/202314:00GlobeNewswire Inc.Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin TriagonistNASDAQ:RANIRani Therapeutics Holdings Inc
08/11/202322:05GlobeNewswire Inc.Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
01/11/202321:05GlobeNewswire Inc.Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill® Technology Platform; Reports Preliminary Third QuNASDAQ:RANIRani Therapeutics Holdings Inc
25/10/202314:00GlobeNewswire Inc.The RaniPill® Capsule, Rani Therapeutics’ Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety StudyNASDAQ:RANIRani Therapeutics Holdings Inc
19/10/202322:05GlobeNewswire Inc.Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical StudyNASDAQ:RANIRani Therapeutics Holdings Inc
12/10/202322:05GlobeNewswire Inc.Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral ResearchNASDAQ:RANIRani Therapeutics Holdings Inc
18/09/202314:00GlobeNewswire Inc.Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43)NASDAQ:RANIRani Therapeutics Holdings Inc
07/09/202322:05GlobeNewswire Inc.Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical StudiesNASDAQ:RANIRani Therapeutics Holdings Inc
11/08/202322:05GlobeNewswire Inc.Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RANI

La tua Cronologia

COIN
HNSUSD
Handshake
NASDAQI
CALY
BlackRock Short-Term Cal...
NASDAQ
CDDKX
Ci G520i 2035 Q1 Fund Cl...
UNSW
0XMRETH
0xMonero
HITB
POWRETH
PowerLedger
NASDAQ
ABMDVXX
Bank of Montreal Autocal...
EU
AXAJF
Axa Banque null
EU
BFCEF
Banque Federative du Cre...
NASDAQ
CBXDX
Ci Canadian Equity Corpo...
KUCN
COSMETH
CosmoCoin
NASDAQ
CFQHX
Ci Portfolio Series Bala...
OKEX
OKBUSDT
OKB
NASDAQ
ABKJJXX
Bank of Montreal Autocal...
EU
BN09B
Bnp Paribas null
BOV
A1ES34
AES
NASDAQ
ABOPBXX
Gs Finance Corp Capped P...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci